JEREMY GOOD: Open Payments
NPI 1104196294 · CHAMPAIGN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 70 payments from 13 companies in 2025. Trend: 2023 $989 · 2024 $1,091 · 2025 $1,335
Food & beverage: $1,267Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $338 |
| Sumitomo Pharma America, Inc. | 14 | $254 |
| Olympus America Inc. | 20 | $239 |
| PFIZER INC. | 5 | $117 |
| Endo USA, Inc. | 5 | $107 |
| Ferring Pharmaceuticals Inc. | 4 | $86 |
| ABBVIE INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: ERLEADA, iTIND System, GEMTESA, XTANDI, ORGOVYX, ADSTILADRIN, XIAFLEX, LUPRON DEPOT.
Industry payments across IL — which companies pay providers there.
